Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07017283Recruiting
Comparing two sedation methods for older adults having ERCP
This study compares two ways of keeping you comfortable and safe during an ERCP procedure: deeper sedation with a breathing tube versus deep sedation without a breathing tube. It aims to find which method causes fewer side effects in older adults.
Hangzhou, ZhijiangAges 60 years+ - NCT07017673RecruitingPhase 2
Ivonescimab with chemo for early-stage triple negative breast cancer
This trial tests a new drug, ivonescimab, combined with standard chemotherapy before surgery for people with high-risk early-stage triple negative breast cancer. The goal is to see if adding this drug improves treatment response.
Los Angeles, CaliforniaAges 18 years+ - NCT07017985Recruiting
Diabetes in patients having first lower back surgery
This study looks at how common diabetes is in people about to have their first lower back surgery (lumbar spine surgery). It aims to help doctors better understand the link between diabetes and spine health.
MassyAges 18 years+ - NCT07018037Recruiting
TTV levels during first immunotherapy for kidney cancer
This study looks at whether a virus called TTV (torque teno virus) in the blood can help predict how well immunotherapy works for advanced kidney cancer. If you have clear cell renal cell carcinoma that has spread and are about to start your first immunotherapy, you may be able to join.
Rome, RomeAges 18 years+ - NCT07018180Recruiting
Patch to help keep your CGM sensor on
This trial tests a special patch that helps keep continuous glucose monitor (CGM) sensors in place longer. It is for people with diabetes who have trouble keeping their sensor on and have high blood sugar levels.
BronAges 6 years+ - NCT07018336Recruiting
Mirror therapy vs virtual reality for arm recovery after stroke
This study compares two therapies—mirror therapy and virtual reality—to help improve arm and hand function in people who have had a stroke. It aims to find which approach works better for recovery.
Istanbul, GaziosmanpaşaAges 18–75 - NCT07018557RecruitingPhase 4
Eszopiclone for sleep and blood pressure in insomnia with high blood pressure
This trial tests if a sleep medication (eszopiclone) can lower blood pressure in people who have both insomnia and high blood pressure. You may qualify if you have trouble sleeping and your blood pressure is not well controlled despite treatment.
São Paulo, São PauloAges 30–75 - NCT07018570RecruitingPhase 2
Chemo, immunotherapy, and radiation for stomach cancer before surgery
This trial tests a combination of chemotherapy (FLOT), an immunotherapy drug (pembrolizumab), and short-course radiation before surgery for gastroesophageal junction cancer. The goal is to see if this approach improves outcomes.
Kashiwa, ChibaAges 18 years+ - NCT07018791RecruitingPhase 3
Art-based pain test for jaw joint disorder patients
This trial tests if using art can help measure pain in people with temporomandibular joint disorders (TMD). It may offer a new way to understand and manage your pain without surgery.
Jeddah, Mecca RegionAges 18 years+ - NCT07019116Recruiting
AI to help manage specialist referrals
This study tests if artificial intelligence (AI) can help decide which referrals to specialists can be managed by primary care instead. It might lead to faster care for patients who truly need a specialist.
Porto Alegre, Rio Grande do SulAges Any age - NCT07019246Recruiting
Sedative drug mix for elderly abdominal surgery patients
This trial tests whether a mix of two sedative drugs (etomidate and propofol) is safer than using propofol alone for elderly patients having abdominal surgery. It aims to find which approach leads to fewer side effects during and after the procedure.
Wuhan, HubeiAges 65–80 - NCT07019363RecruitingPhase 3
CDK4/6 inhibitor plus hormone therapy for high-risk breast cancer
This trial tests whether adding a CDK4/6 inhibitor (a type of targeted pill) to standard hormone therapy after surgery can lower the risk of breast cancer coming back in women with high-risk, hormone-receptor-positive, HER2-positive early breast cancer.
ShanghaiAges 18–70 - NCT07019493Recruiting
Young stroke recovery study for ages 18 to 55
This study looks at how young adults recover from a stroke. Researchers want to learn more about what helps recovery in the first few months after a stroke.
Heidelberg, VictoriaAges 18–55 - NCT07019506Recruiting
Exercise for heart health in cardiovascular disease patients
This trial tests whether a program of 20 physical exercise sessions can improve your aerobic capacity (how well your body uses oxygen during activity). If you have been diagnosed with heart or blood vessel disease and are a patient at Clínica el Rosario, this study may help you understand how exercise can benefit you.
MedellínAges 35–90 - NCT07019519Recruiting
Gut hormones and blood flow in POTS
This study looks at how gut hormones control blood flow after eating in people with POTS. It may help explain symptoms like dizziness and rapid heartbeat after meals.
CopenhagenAges 18–50 - NCT07019675RecruitingPhase 2
Study of a new drug for people with lung cancer
This trial tests a new medication, SKB518, for people with non-small cell or small cell lung cancer who have at least one measurable tumor and are in fairly good health. It aims to see if the drug can help shrink tumors or slow the cancer's growth.
Shenzhen, GuangdongAges 18–75 - NCT07020065RecruitingPhase 2
Reduced chemo plus immunotherapy vs immunotherapy alone for older lung cancer patients
This trial tests whether a reduced dose of chemotherapy plus an immunotherapy drug (Cemiplimab) works better than Cemiplimab alone for older or frail patients with advanced lung cancer whose PD-L1 level is below 50%. It aims to find a gentler but effective treatment option.
Fribourg, Villars-sur-GlâneAges 70 years+ - NCT07020221RecruitingPhase 1/Phase 2
Study of VS-7375 for KRAS G12D solid tumors
This trial tests a new oral drug called VS-7375 for people with advanced solid tumors that have a specific KRAS G12D mutation. The goal is to see if it can shrink tumors or slow their growth.
Los Angeles, CaliforniaAges 18 years+ - NCT07020611Recruiting
Lining Aneurysm Sac in Abdominal Aortic Aneurysm
This early study tests a new device that lines the aneurysm sac (the outer wall) during standard stent-graft repair for abdominal aortic aneurysm. It aims to see if the lining helps prevent the aneurysm from growing or leaking over time.
AucklandAges 18 years+ - NCT07020910Recruiting
Heart rhythm registry for patients at the Heart Center Bad Berka
This registry collects information from patients with heart rhythm problems (arrhythmias) who are treated at the Heart Center in Bad Berka. It helps doctors learn more about these conditions and improve care.
Bad BerkaAges 18 years+ - NCT07021196Recruiting
Home exercise program for breast or prostate cancer patients
This study tests a home-based exercise program designed just for you, tailored using a smartphone or tablet. It aims to help people with breast or prostate cancer get stronger and feel better after surgery.
NaplesAges 18–80 - NCT07021222Recruiting
Preventing foot sores in diabetes
This study looks at ways to prevent foot sores in people with type 2 diabetes. It enrolls two groups: those at risk but without past sores, and those whose sores have healed for at least 6 months.
Bologna, BOAges 18–75 - NCT07021612Recruiting
Registry study of TAVI for severe aortic regurgitation
This study is for people with a severe leaking aortic valve (aortic regurgitation) who are too high-risk for open-heart surgery. It tracks how well a less-invasive valve replacement (TAVI) using the JenaValve or J-Valve works for them.
Hong Kong, ShatinAges 18 years+ - NCT07021898RecruitingPhase 1
ERAS-4001 for advanced solid tumors with mutations
This trial tests a new oral drug called ERAS-4001 for people with advanced solid tumors that have a specific genetic change and are no longer helped by standard treatments. It aims to see if the drug is safe and can shrink tumors.
Nashville, TennesseeAges 18–99
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.